Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
How Gene Therapy sponsors can overcome regulatory approval bottlenecks.
In a previous article, we discussed the findings of a Linkedin poll regarding…
How are digital health applications and AI transforming healthcare?
When thinking of health apps, the most common ones coming into our minds are…
